Preparation of nanoscale pulmonary drug delivery formulations by spray drying

Advances in Experimental Medicine and Biology

Volumn 811, Issue , 2014, Pages 183-206

  Bohr, Adam ^a   Ruge, Christian A ^a   Beck Broichsitter, Moritz ^a  

^a UNIV PARIS SUD   (France)

Author keywords

Aerosol; Cell culture models; Isolated lung technique; Nano embedded microparticles; Nanoparticles; Pulmonary drug delivery; Spray drying

Indexed keywords

DRUG; LUNG SURFACTANT; NANOPARTICLE;

AEROSOL; ARTICLE; BRONCHUS MUCOSA; BRONCHUS MUCUS; CILIATED EPITHELIUM CELL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG UPTAKE; ELECTROHYDRODYNAMIC ATOMIZATION; FREEZE DRYING; INHALATIONAL DRUG ADMINISTRATION; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; LUNG MODEL; LUNG STRUCTURE; MUCOCILIARY CLEARANCE; NANOEMBEDDED MICROPARTICLE; NANOMEDICINE; NANOTECHNOLOGY; NEBULIZATION; PRIORITY JOURNAL; PULMONARY DRUG DELIVERY FORMULATION; PYROLYSIS; RESPIRATORY DRUG ADMINISTRATION; SPRAY DRYING; SPRAY FREEZE DRYING; SUPERCRITICAL FLUID; ANIMAL; ARTIFICIAL VENTILATION; CHEMISTRY; DESICCATION; HUMAN; LUNG; METHODOLOGY; REVIEW;

ADMINISTRATION, INHALATION; ANIMALS; DESICCATION; DRUG DELIVERY SYSTEMS; HUMANS; LUNG; NANOPARTICLES; RESPIRATORY THERAPY;

EID: 84904309907     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-94-017-8739-0_10     Document Type: Article

References (84)

1. Patton JS, Byron PR (2007) Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67-74
2. Ruge CA, Kirch J, Lehr CM (2013) Pulmonary drug delivery: from generating aerosols to overcoming biological barriers -therapeutic possibilities and technological challenges. Lancet Respir Med 1:402-413
3. Sanders N, Rudolph C, Braeckmans K et al (2009) Extracellular barriers in respiratory gene therapy. Adv Drug Deliv Rev 61:115-127
4. Sung JC, Pulliam BL, Edwards DA (2007) Nanoparticles for drug delivery to the lungs. Trends Biotechnol 25:563-570
5. Patton JS, Brain JD, Davies LA et al (2010) The particle has landed -characterizing the fate of inhaled pharmaceuticals. J Aerosol Med 23:S71-S87
6. Yang W, Peters JI, Williams RO 3rd (2008) Inhaled nanoparticles -a current review. Int J Pharm 356:239-247
7. Peltonen L, Valo H, Kolakovic R et al (2010) Electrospraying, spray drying and related techniques for production and formulation of drug nanoparticles. Expert Opin Drug Deliv 7:705-719
8. Gehr P, Bachofen M, Weibel ER (1978) The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 32:121-140
9. Weibel ER (1973) Morphological basis of alveolarcapillary gas exchange. Physiol Rev 53:419-495
10. Reynolds SD, Malkinson AM (2010) Clara cell: progenitor for the bronchiolar epithelium. Int J Biochem Cell Biol 42:1-4
11. Steimer A, Haltner E, Lehr CM (2005) Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med 18:137-182
12. Wong AP, Keating A, Waddell TK (2009) Airway regeneration: the role of the Clara cell secretory protein and the cells that express it. Cytotherapy 11:676-687
13. Crapo JD, Barry BE, Gehr P et al (1982) Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126:332-337
14. Goerke J (1998) Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1408:79-89
15. Geiser M (2010) Update on macrophage clearance of inhaled micro-and nanoparticles. J Aerosol Med 23:207-217
16. Stone KC, Mercer RR, Gehr P et al (1992) Allometric relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 6:235-243
17. Geiser M, Schuerch S, Gehr P (2003) Influence of surface chemistry and topography of particles on their immersion into the lung's surface-lining layer. J Appl Physiol 94:1793-1801
18. Schuerch S, Gehr P, Im Hof V et al (1990) Surfactant displaces particles toward the epithelium in airways and alveoli. Respir Physiol 80:17-32
19. Cone RA (2009) Barrier properties of mucus. Adv Drug Deliv Rev 61:75-85
20. Ryser M, Burn A, Wessel T et al (2007) Functional imaging of mucociliary phenomena: high-speed digital reflection contrast microscopy. Eur Biophys J 37:35-54
21. Olsson B, Bondesson E, Borgstroem L (2011) Pulmonary drug metabolism, clearance, and absorption. In: Smyth HDC, Hickey AJ (eds) Controlled pulmonary drug delivery, 1st edn. Springer, New York, pp 21-50
22. Patton JS (1996) Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3-36
23. Ensign LM, Henning A, Schneider CS et al (2013) Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. Mol Pharm 10:2176-2182
24. Kirch J, Schneider A, Abou B et al (2012) Optical tweezers reveal relationship between microstructure and nanoparticle penetration of pulmonary mucus. Proc Natl Acad Sci U S A 109:18355-18360
25. Wang YY, Lai SK, Suk JS et al (2008) Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew Chem Int Ed Engl 47:9726-9729
26. Bastacky J, Lee CY, Goerke J et al (1995) Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol 79:1615-1628
27. Blanco O, Perez-Gil J (2007) Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat Respiratory Distress Syndrome: role of the different components in an efficient pulmonary surfactant. Eur J Pharmacol 568:1-15
28. Phelps DS (2001) Surfactant regulation of host defense function in the lung: a question of balance. Pediatr Pathol Mol Med 20:269-292
29. Ruge CA, Kirch J, Canadas O et al (2011) Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 7:690-693
30. Ruge CA, Schaefer UF, Herrmann J et al (2012) The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One 7:e40775
31. Rabinow BE (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785-796
32. Biskos G, Vons V, Yurteri CU et al (2008) Generation and sizing of particles for aerosol-based nanotechnology. KONA Powder Part J 26:13-35
33. Cal K, Sollohub K (2010) Spray drying technique. I. Hardware and process parameters. J Pharm Sci 99:575-586
34. Sollohub K, Cal K (2010) Spray drying technique: II. Current applications in pharmaceutical technology. J Pharm Sci 99:587-597
35. Vehring R, Foss WR, Lechuga-Ballesteros D (2007) Particle formation in spray drying. J Aerosol Sci 38:728-746
36. Vehring R (2008) Pharmaceutical particle engineering via spray drying. Pharm Res 25:999-1022
37. Okuyama K, Lenggoro IW (2003) Preparation of nanoparticles via spray route. Chem Eng Sci 58: 537-547
38. Nandiyanto ABD, Okuyama K (2011) Progress in developing spray-drying methods for the production of controlled morphology particles: from the nanometer to submicrometer size ranges. Adv Powder Technol 22:1-19
39. Heng D, Lee SH, Ng WK et al (2011) The nano spray dryer B-90. Expert Opin Drug Deliv 8:965-972
40. Lee SH, Heng D, Ng WK et al (2011) Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Int J Pharm 403:192-200
41. Wang Z, Finlay WH, Peppler M et al (2006) Powder formation by atmospheric spray-freeze-drying. Powder Technol 170:45-52
42. Topp MN (1973) Ultrasonic atomization-a photographic study of the mechanism of disintegration. J Aerosol Sci 4:17-25
43. Yurteri CU, Hartman RPA, Marijnissen JCM (2010) Producing pharmaceutical particles via electrospraying with an emphasis on nano and nano structured particles -a review. KONA Powder Part J 28:91-115
44. Leuenberger H (2002) Spray freeze-drying -the process of choice for low water soluble drugs? J Nanopart Res 4:111-119
45. Cheow WS, Ng ML, Kho K et al (2011) Spray-freezedrying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Int J Pharm 404:289-300
46. Forde G, Friend J, Williamson T (2006) Straightforward biodegradable nanoparticle generation through megahertz-order ultrasonic atomization. Appl Phys Lett 89:064105-064105-3
47. Bittner B, Kissel T (1999) Ultrasonic atomization for spray drying: a versatile technique for the preparation of protein loaded biodegradable microspheres. J Microencapsul 16:325-341
48. York P (1999) Strategies for particle design using supercritical fluid technologies. Pharm Sci Technol Today 2:430-440
49. Sethia S, Squillante E (2004) Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 272:1-10
50. Byrappa K, Ohara S, Adschiri T (2008) Nanoparticles synthesis using supercritical fluid technology -towards biomedical applications. Adv Drug Deliv Rev 60:299-327
51. Jaworek A (2007) Micro-and nanoparticle production by electrospraying. Powder Technol 176:18-35
52. Ganan-Calvo AM (1999) The surface charge in electrospraying: its nature and its universal scaling laws. J Aerosol Sci 30:863-872
53. Jaworek A, Sobczyk AT (2008) Electrospraying route to nanotechnology: an overview. J Electrostat 66:197-219
54. Marijnissen JCM, Gradon L (2010) Nanoparticles in medicine and environment: inhalation and health effects. J Aerosol Med 23:339-341
55. Enayati M, Ahmad Z, Stride E et al (2010) One-step electrohydrodynamic production of drug-loaded micro-and nanoparticles. J R Soc Interface 7:667-675
56. Valo H, Peltonen L, Vehvilaeinen S et al (2009) Electrospray encapsulation of hydrophilic and hydrophobic drugs in poly(L-lactic acid) nanoparticles. Small 5:1791-1798
57. Heyder J, Gebhardt J, Rudolf G et al (1986) Deposition of particles in the human respiratory tract in the size range 0.005-15 μm. J Aerosol Sci 17:811-825
58. Cook RO, Pannu RK, Kellaway IW (2005) Novel sustained release microspheres for pulmonary drug delivery. J Control Release 104:79-90
59. Mizoe T, Ozeki T, Okada H (2007) Preparation of drug nanoparticle-containing microparticles using a 4-fluid nozzle spray drier for oral, pulmonary, and injection dosage forms. J Control Release 122:10-15
60. Ely L, Roa W, Finlay WH et al (2007) Effervescent dry powder for respiratory drug delivery. Eur J Pharm Biopharm 65:346-353
61. Yamamoto H, Hoshina W, Kurashima H et al (2007) Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system. Adv Powder Technol 18:215-228
62. Azarmi S, Tao X, Chen H et al (2006) Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Int J Pharm 319:155-161
63. Grenha A, Seijo B, Remunan-Lopez C (2005) Microencapsulated chitosan nanoparticles for lung protein delivery. Eur J Pharm Sci 25:427-437
64. Sham JOH, Zhang Y, Finlay WH et al (2004) Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung. Int J Pharm 269:457-467
65. Hadinoto K, Zhu K, Tan RBH (2007) Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery. Int J Pharm 341:195-206
66. Jensen DMK, Cun D, Maltesen MJ et al (2010) Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation. J Control Release 142:138-145
67. Tsapis N, Bennett D, Jackson B et al (2002) Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci U S A 99:12001-12005
68. Heyder J (2004) Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery. Proc Am Thorac Soc 1:315-320
69. Beck-Broichsitter M, Merkel OM, Kissel T (2012) Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Control Release 161:214-224
70. Beck-Broichsitter M, Schweiger C, Schmehl T et al (2012) Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery. J Control Release 158:329-335
71. Beck-Broichsitter M, Knuedeler MC, Schmehl T et al (2013) Following the concentration of polymeric nanoparticles during nebulization. Pharm Res 30:16-24
72. Watts AB, McConville JT, Williams RO III (2008) Current therapies and technological advances in aqueous aerosol drug delivery. Drug Dev Ind Pharm 34:913-922
73. Anton N, Jakhmola A, Vandamme TF (2012) Trojan microparticles for drug delivery. Pharmaceutics 4:1-25
74. Forbes B, Ehrhardt C (2005) Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 60:193-205
75. Lehmann A, Daum N, Bur M et al (2011) An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm 77:398-406
76. Rothen-Rutishauser B, Mueller L, Blank F et al (2008) A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. ALTEX 25:191-196
77. Paur HR, Cassee FR, Teeguarden JG et al (2011) In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung -a dialog between aerosol science and biology. J Aerosol Sci 42:668-692
78. Lenz A, Karg E, Lentner B et al (2009) A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles. Part Fibre Toxicol 6:32
79. Hein S, Bur M, Schaefer UF et al (2011) A new Pharmaceutical Aerosol Deposition Device on Cell Cultures (PADDOCC) to evaluate pulmonary drug absorption for metered dose dry powder formulations. Eur J Pharm Biopharm 77:132-138
80. Beck-Broichsitter M, Schmehl T, Seeger W et al (2011) Evaluating the controlled release properties of inhaled nanoparticles using isolated, perfused, and ventilated lung models. J Nanomaterials 2011:1-16, article ID 163791
81. Sakagami M (2006) In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58:1030-1060
82. Beck-Broichsitter M, Gauss J, Packhaeuser CB et al (2009) Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model. Int J Pharm 367:169-178
83. Beck-Broichsitter M, Gauss J, Gessler T et al (2010) Pulmonary targeting with biodegradable salbutamolloaded nanoparticles. J Aerosol Med 23:47-57
84. Rytting E, Bur M, Cartier R et al (2010) In vitro and in vivo performance of biocompatible negativelycharged salbutamol-loaded nanoparticles. J Control Release 141:101-107